Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells

被引:0
|
作者
Patricia Midori Murobushi Ozawa
Faris Alkhilaiwi
Iglenir João Cavalli
Danielle Malheiros
Enilze Maria de Souza Fonseca Ribeiro
Luciane Regina Cavalli
机构
[1] Georgetown University Medical Center,Department of Oncology, Lombardi Comprehensive Cancer Center
[2] Federal University of Paraná,Department of Genetics
[3] King Abdulaziz University,Faculty of Pharmacy
来源
Breast Cancer Research and Treatment | 2018年 / 172卷
关键词
TNBC; Exosomes; Proliferation; Drug resistance; Gene expression; miRNA expression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:713 / 723
页数:10
相关论文
共 50 条
  • [21] Substrate stiffness modulates extracellular vesicles' release in a triple-negative breast cancer model
    Senigagliesi, Beatrice
    Geiss, Otmar
    Valente, Stefano
    Vondracek, Hendrik
    Cefarin, Nicola
    Ceccone, Giacomo
    Calzolai, Luigi
    Ballerini, Laura
    Parisse, Pietro
    Casalis, Loredana
    EXTRACELLULAR VESICLES AND CIRCULATING NUCLEIC ACIDS, 2024, 5 (03): : 653 - 668
  • [22] DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
    Ogbu, Stella C.
    Rojas, Samuel
    Weaver, John
    Musich, Phillip R.
    Zhang, Jinyu
    Yao, Zhi Q.
    Jiang, Yong
    CELLS, 2022, 11 (01)
  • [23] GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies
    Khoa Nguyen
    McConnell, Emily
    Edwards, Orielle
    Collins-Burow, Bridgette M.
    Burow, Matthew E.
    CANCER DRUG RESISTANCE, 2022, 5 (03) : 721 - 726
  • [24] Downregulation of RIP140 in triple-negative breast cancer inhibits the growth and proliferation of cancer cells
    Yu, Xiao-Hong
    Xue, Xiaodong
    Zhu, Xun
    Li, Xia
    ONCOLOGY LETTERS, 2018, 15 (06) : 8784 - 8788
  • [25] Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells
    Wang, Zhonghua
    Jin, Jia
    Zhan, Jian
    Wang, Leiping
    Cao, Jun
    ONCOLOGY REPORTS, 2016, 36 (04) : 2071 - 2078
  • [26] Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer
    Li, Wenlong
    Yang, Hongmei
    Li, Xiaoli
    Han, Lou
    Xu, Ning
    Shi, Aiping
    ONCOLOGY REPORTS, 2019, 41 (01) : 437 - 446
  • [27] The roles of small extracellular vesicles as prognostic biomarkers and treatment approaches in triple-negative breast cancer
    Zhou, Yueyuan
    Xiao, Zhongdang
    Zhu, Wei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells
    Kavanagh, E. L.
    Lindsay, S.
    Halasz, M.
    Gubbins, L. C.
    Weiner-Gorzel, K.
    Guang, M. H. Z.
    McGoldrick, A.
    Collins, E.
    Henry, M.
    Blanco-Fernandez, A.
    Gorman, P. O'
    Fitzpatrick, P.
    Higgins, M. J.
    Dowling, P.
    McCann, A.
    ONCOGENESIS, 2017, 6 : e388 - e388
  • [29] Triple negative breast cancer-derived small extracellular vesicles as modulator of biomechanics in target cells
    Senigagliesi, Beatrice
    Samperi, Giuseppe
    Cefarin, Nicola
    Gneo, Luciana
    Petrosino, Sara
    Apollonio, Mattia
    Caponnetto, Federica
    Sgarra, Riccardo
    Collavin, Licio
    Cesselli, Daniela
    Casalis, Loredana
    Parisse, Pietro
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2022, 44
  • [30] Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells
    Marczyk, Michal
    Patwardhan, Gauri A.
    Zhao, Jun
    Qu, Rihao
    Li, Xiaotong
    Wali, Vikram B.
    Gupta, Abhishek K.
    Pillai, Manoj M.
    Kluger, Yuval
    Yan, Qin
    Hatzis, Christos
    Pusztai, Lajos
    Gunasekharan, Vignesh
    CANCERS, 2020, 12 (09) : 1 - 23